It has been found that MFN2 deficiency reduces PS metastasis and alters phospholipid metabolism, resulting in ER stress and promoting hepatocarcinogenesis in a non‐alcoholic steatohepatitis (NASH) mouse MFN2 re‐expression experiment.74 This evidence concerns the gene MFN2 and metabolic dysfunction-associated steatohepatitis.